New Zealand researchers are working on a new clinical decision-making tool that will be able to help clinicians weigh up the benefits and harms of long-term aspirin use for the prevention of cardiovascular disease on individual patients.

Researchers from the University of Auckland’s Faculty of Medical and Health Sciences and Middlemore Hospital have developed bleeding risk models for men and women that are able to provide a personalised estimate of a patient’s risk of a major bleed.